These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 34328587)

  • 41. Immunotherapy for triple-negative breast cancer: Existing challenges and exciting prospects.
    Jia H; Truica CI; Wang B; Wang Y; Ren X; Harvey HA; Song J; Yang JM
    Drug Resist Updat; 2017 May; 32():1-15. PubMed ID: 29145974
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic role of chemotherapy, radiotherapy dose, and extent of surgical resection in adult medulloblastoma.
    Haque W; Verma V; Brian Butler E; Teh BS
    J Clin Neurosci; 2020 Jun; 76():154-160. PubMed ID: 32291240
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current therapy and new perspectives in the treatment of medulloblastoma.
    Whelan HT; Krouwer HG; Schmidt MH; Reichert KW; Kovnar EH
    Pediatr Neurol; 1998 Feb; 18(2):103-15. PubMed ID: 9535295
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Understanding medulloblastoma.
    Quinlan A; Rizzolo D
    JAAPA; 2017 Oct; 30(10):30-36. PubMed ID: 28953021
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment results of adults and children with medulloblastoma NCI, Cairo University experience.
    Khalil EM
    J Egypt Natl Canc Inst; 2008 Jun; 20(2):175-86. PubMed ID: 20029474
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immune Dysfunctions and Immune-Based Therapeutic Interventions in Chronic Lymphocytic Leukemia.
    Griggio V; Perutelli F; Salvetti C; Boccellato E; Boccadoro M; Vitale C; Coscia M
    Front Immunol; 2020; 11():594556. PubMed ID: 33312177
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Current multimodality management of medulloblastoma.
    Paulino AC
    Curr Probl Cancer; 2002; 26(6):317-56. PubMed ID: 12447347
    [No Abstract]   [Full Text] [Related]  

  • 48. Shedding light on adult medulloblastoma: current management and opportunities for advances.
    Brandes AA; Franceschi E
    Am Soc Clin Oncol Educ Book; 2014; ():e82-7. PubMed ID: 24857151
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Large cell/anaplastic medulloblastoma is associated with poor prognosis-a retrospective analysis at a single institute.
    Huang PI; Lin SC; Lee YY; Ho DM; Guo WY; Chang KP; Chang FC; Liang ML; Chen HH; Liu YM; Yen SH; Wong TT; Chen YW
    Childs Nerv Syst; 2017 Aug; 33(8):1285-1294. PubMed ID: 28488086
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of and prognosis with medulloblastoma: therapy at a crossroads.
    Packer RJ; Vezina G
    Arch Neurol; 2008 Nov; 65(11):1419-24. PubMed ID: 19001159
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Medulloblastoma as a first presentation of fanconi anemia.
    Tischkowitz MD; Chisholm J; Gaze M; Michalski A; Rosser EM
    J Pediatr Hematol Oncol; 2004 Jan; 26(1):52-5. PubMed ID: 14707715
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Pediatric medulloblastoma presenting as cerebellar hemorrhage: a case report].
    Furuhata M; Aihara Y; Eguchi S; Horiba A; Tanaka M; Komori T; Okada Y
    No Shinkei Geka; 2014 Jun; 42(6):545-51. PubMed ID: 24920742
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Evolution of the management of pediatric and adult medulloblastoma].
    Vigneron C; Entz-Werlé N; Lutz P; Spiegel A; Jannier S; Helfre S; Alapetite C; Coca A; Kehrli P; Noël G
    Cancer Radiother; 2015 Aug; 19(5):347-57; quiz 358-9, 362. PubMed ID: 26141663
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cellular immunotherapy for medulloblastoma.
    Schakelaar MY; Monnikhof M; Crnko S; Pijnappel EW; Meeldijk J; Ten Broeke T; Bovenschen N
    Neuro Oncol; 2023 Apr; 25(4):617-627. PubMed ID: 36219688
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development and cancer of the cerebellum.
    Hatten ME; Roussel MF
    Trends Neurosci; 2011 Mar; 34(3):134-42. PubMed ID: 21315459
    [TBL] [Abstract][Full Text] [Related]  

  • 56. From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma.
    Fu Y; Liu S; Zeng S; Shen H
    J Exp Clin Cancer Res; 2019 Sep; 38(1):396. PubMed ID: 31500650
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Medulloblastoma in Older Adults: A Case Report and Literature Review.
    Murase M; Saito K; Abiko T; Yoshida K; Tomita H
    World Neurosurg; 2018 Sep; 117():25-31. PubMed ID: 29883827
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Medulloblastoma: conventional radiation therapy in comparison to chemo radiation therapy in the post-operative treatment of high-risk patients.
    Abd El-Aal HH; Mokhtar MM; Habib E; El-Kashef AT; Fahmy ES
    J Egypt Natl Canc Inst; 2005 Dec; 17(4):301-7. PubMed ID: 17102823
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Medulloblastoma in China: clinicopathologic analyses of SHH, WNT, and non-SHH/WNT molecular subgroups reveal different therapeutic responses to adjuvant chemotherapy.
    Zhang ZY; Xu J; Ren Y; Li KK; Ng HK; Mao Y; Zhong P; Yao Y; Zhou LF
    PLoS One; 2014; 9(6):e99490. PubMed ID: 24932704
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Medulloblastoma: what is the role of molecular genetics?
    Entz-Werle N; Carli ED; Ducassou S; Legrain M; Grill J; Dufour C
    Expert Rev Anticancer Ther; 2008 Jul; 8(7):1169-81. PubMed ID: 18588461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.